Direct inhibition of glucagon signaling, however, raises safety concerns as it causes α cell hyperplasia, a possible precursor lesion of pancreatic neuroendocrine tumors (PNETs) [8]–[14]. This evidence concerns the gene GCG and pancreatic neuroendocrine tumor.